The Molecular Technique Core will provide a central resource for DNA sequencing using an automated genotyping machine, as well as a resource for in situ hybridization analysis. This unit represents a significant and critical component of this Program Project. We designed a well planned facility to analyze STSs of various sizes, microsatellites, to restriction map larger phase and cosmid clones and to perform automated sequencing to met the needs of the individual investigators. All Project Investigators need to use the ABI Prism Genotyping Machine. In situ hybridization is an ideal method to determine the differential expression of genes regulating cellular differentiation during spermatogenesis. Projects II and III propose to use in situ hybridization to characterize new genes involved in spermatogenesis and testicular descent. Nevertheless, the fixatives and techniques commonly used to prepare other mammalian organ tissues for in-situ hybridization severely distort the delicate testicular architecture, thwarting attempts to identify cell- and stage-specific genes expressed during spermatogenic proliferation and differentiation. While preserving the mRNA signal, formalin fixation and frozen tissue sectioning distorts testicular histology and renders unobtainable the very architectural information necessary to localize gene expression. Based upon modification of the methodology by our laboratory, we have optimized a method for in situ hybridization for testicular tissue. This Core will also provide in situ hybridization as a service to Project Investigators.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
1P01HD036289-01A2
Application #
6331739
Study Section
Special Emphasis Panel (ZHD1-PRG-G (DL))
Project Start
2000-05-10
Project End
2005-04-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
$175,752
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Gomez, Lissette; Kovac, Jason R; Lamb, Dolores J (2015) CYP17A1 inhibitors in castration-resistant prostate cancer. Steroids 95:80-7
Eisenberg, Michael L; Li, Shufeng; Betts, Paul et al. (2015) Testosterone therapy and cancer risk. BJU Int 115:317-21
Jorgez, Carolina J; Wilken, Nathan; Addai, Josephine B et al. (2015) Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia. Fertil Steril 103:44-52.e1
Eisenberg, M L; Li, S; Herder, D et al. (2015) Testosterone therapy and mortality risk. Int J Impot Res 27:46-8
Carrell, D T; Nyboe Andersen, A; Lamb, D J (2015) The need to improve patient care through discriminate use of intracytoplasmic sperm injection (ICSI) and improved understanding of spermatozoa, oocyte and embryo biology. Andrology 3:143-6
Garcia, Jose M; Chen, Ji-an; Guillory, Bobby et al. (2015) Ghrelin Prevents Cisplatin-Induced Testicular Damage by Facilitating Repair of DNA Double Strand Breaks Through Activation of p53 in Mice. Biol Reprod 93:24
Eisenberg, Michael L; Li, Shufeng; Behr, Barry et al. (2014) Semen quality, infertility and mortality in the USA. Hum Reprod 29:1567-74
Kovac, Jason R; Rajanahally, Saneal; Smith, Ryan P et al. (2014) Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med 11:553-62
Kovac, Jason R; Pan, Michael M; Lipshultz, Larry I et al. (2014) Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids 89:27-32
Kovac, Jason R; Kovac, Jason; Pastuszak, Alexander W et al. (2014) Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad Med 126:149-56

Showing the most recent 10 out of 72 publications